The spectrum of the dyslipidemia in Colombia: The PURE study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 12 06 2018
revised: 09 10 2018
accepted: 25 10 2018
pubmed: 23 11 2018
medline: 7 1 2020
entrez: 23 11 2018
Statut: ppublish

Résumé

Dyslipidemia is a major risk factor for cardiovascular diseases (CVD). Worldwide, a third of ischemic heart disease is due to abnormal cholesterol levels and it is the most common cause of cardiovascular deaths in Colombia. In Colombia, no representative, large-scale study has assessed the prevalence of dyslipidemia. The aim of the present analysis was to identify the magnitude of the problem in Colombia, a middle-income-country with large regional, geographic, and socio-economical differences. The sample comprised 6628 individuals aged 35 to 70 years (mean age 50.7 years, 64.1% women) residing in the four Colombian regions. The overall prevalence of dyslipidemia was 87.7% and was substantially higher among participants older than 50 years, male, rural residents, and those with a lower level of education (66.8%), and with a lower income (66.4%). High non HDL-c was the most common abnormality (75.3%). The values of total cholesterol and non-HDL-cholesterol were higher in areas with the lowest health needs index than in the areas with intermediate and highest health need index, the isolated HDL-c value was much lower. Colombia has a high prevalence of abnormalities of the lipid profile. The causes of the high rates of dyslipidemia were not well define in this study, but were more common in rural and poorer regions and among those with lower socio-economical status. Strategies to tackle the adverse lipid profile to reduce CVD are needed in Colombia, particularly in rural areas and among the areas with the higher health need index.

Sections du résumé

BACKGROUND
Dyslipidemia is a major risk factor for cardiovascular diseases (CVD). Worldwide, a third of ischemic heart disease is due to abnormal cholesterol levels and it is the most common cause of cardiovascular deaths in Colombia. In Colombia, no representative, large-scale study has assessed the prevalence of dyslipidemia. The aim of the present analysis was to identify the magnitude of the problem in Colombia, a middle-income-country with large regional, geographic, and socio-economical differences.
MATERIAL AND METHODS
The sample comprised 6628 individuals aged 35 to 70 years (mean age 50.7 years, 64.1% women) residing in the four Colombian regions.
RESULTS
The overall prevalence of dyslipidemia was 87.7% and was substantially higher among participants older than 50 years, male, rural residents, and those with a lower level of education (66.8%), and with a lower income (66.4%). High non HDL-c was the most common abnormality (75.3%). The values of total cholesterol and non-HDL-cholesterol were higher in areas with the lowest health needs index than in the areas with intermediate and highest health need index, the isolated HDL-c value was much lower.
CONCLUSION
Colombia has a high prevalence of abnormalities of the lipid profile. The causes of the high rates of dyslipidemia were not well define in this study, but were more common in rural and poorer regions and among those with lower socio-economical status. Strategies to tackle the adverse lipid profile to reduce CVD are needed in Colombia, particularly in rural areas and among the areas with the higher health need index.

Identifiants

pubmed: 30463681
pii: S0167-5273(18)33673-8
doi: 10.1016/j.ijcard.2018.10.090
pii:
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-117

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Paul A Camacho (PA)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia; Universidad Autónoma de Bucaramanga (UNAB), Bucaramanga, Colombia.

Johanna Otero (J)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.

Maritza Pérez (M)

Facultad de Medicina, Universidad Militar Nueva Granada, Bogotá, Colombia.

Edgar Arcos (E)

Fundación Cometa, Pasto, Colombia.

Henry García (H)

Fundación RIESCARD, El Espinal, Colombia.

Claudia Narvaez (C)

Hospital Susana López de Valencia, Popayán, Colombia.

Dora I Molina (DI)

Universidad de Caldas - Asociación IPS Médicos Internistas de Caldas, Manizales, Colombia.

Gregorio Sanchez (G)

Universidad del Quindío - Hospital San Juan de Dios, Armenia, Colombia.

Myriam Duran (M)

Universidad de Santander (UDES), Bucaramanga, Colombia.

Carlos Cure (C)

Universidad del Norte - Biolab, Barranquilla, Colombia.

Arístides Sotomayor (A)

Centro Cardiovascular Santa Lucia, Cartagena, Colombia.

Álvaro Rico (Á)

FUNDEMOS, Yopal, Colombia.

Fresia Cotes (F)

Universidad de Santander, Valledupar, Colombia.

Sumathy Rangarajan (S)

Population Health Research Institute (PHRI), McMaster University, Hamilton, Canada.

Salim Yusuf (S)

Population Health Research Institute (PHRI), McMaster University, Hamilton, Canada.

Daniel D Cohen (DD)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia; Universidad de Santander (UDES), Bucaramanga, Colombia.

Silvia González-Gómez (S)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.

Christian Clausen (C)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.

Patricio Lopez-Jaramillo (P)

Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia; Universidad Autónoma de Bucaramanga (UNAB), Bucaramanga, Colombia; Universidad de Santander (UDES), Bucaramanga, Colombia. Electronic address: jplopezj@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH